αB-crystallin: A novel marker of invasive basal-like and metaplastic breast carcinomas

Annals of Diagnostic Pathology

Volumn 12, Issue 1, 2008, Pages 33-40

  Sitterding, Stephanie M ^a   Wiseman, William R ^a   Schiller, Carol L ^a   Luan, Chunyan ^a   Chen, Feng ^a   Moyano, Jose V ^a   Watkin, William G ^b   Wiley, Elizabeth L ^a   Cryns, Vincent L ^a   Diaz, Leslie K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

B crystallin; Basal like; Breast; Breast cancer; Metaplastic

Indexed keywords

ALPHA CRYSTALLIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC VALUE; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; METAPLASIA; MYOEPITHELIUM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; BREAST CYST; BREAST TUMOR; CANCER INVASION; ENZYME IMMUNOASSAY; FEMALE; FIBROCYSTIC BREAST DISEASE; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING;

ADENOCARCINOMA; ALPHA-CRYSTALLIN B CHAIN; BREAST CYST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL PROLIFERATION; FEMALE; FIBROCYSTIC BREAST DISEASE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; METAPLASIA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 37449017051     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2007.02.004     Document Type: Article

References (34)

1. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumors. Nature 406 (2000) 747-752
2. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 (2001) 10869-10874
3. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100 (2003) 8418-8423
4. Nielsen T.O., Hsu F.D., Jensen K., et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10 (2004) 5367-5374
5. Carey L.A., Perou C.M., Livasy C.A., et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295 (2006) 2492-2502
6. Abd El-Rehim D., Pinder S., Paish C., et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 203 (2004) 661-671
7. Putti T.C., Abd El-Rehim D.M., Rakha E.A., et al. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol 18 (2005) 26-35
8. van de Rijn M., Perou C.M., Tibshirani R., et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 161 (2002) 1991-1996
9. Fulford L.G., Easton D.F., and Reis-Filho J.S. Specific morphological features predictive for the basal phenotype of grade 3 invasive ductal carcinoma of breast. Histopatholgy 49 (2006) 22-34
10. Livasy C.A., Karaca G., Nanda R., et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 19 (2006) 264-271
11. Tsuda H., Takarabe T., Hasegawa F., et al. Large, central acellular zones indicating myoepithelial differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol 24 (2000) 197-202
12. Rayson D., Adjei A., Suman V., et al. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol 10 (1999) 413-419
13. Khan H., Wyld L., Dunne B., et al. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol 29 (2003) 600-603
14. Dunne B., Lee A., Pinder S., et al. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum Pathol 34 (2003) 1009-1015
15. Reis-Filho J., Milanezi F., Paredes J., et al. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 11 (2003) 1-8
16. Reis-Filho J.S., Milanezi F., Steele D., et al. Metaplastic beast carcinomas are basal-like tumours. Mod Pathol 49 (2006) 10-21
17. Moyano J.V., Evans J.R., Chen F., et al. alphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest 116 (2006) 261-270
18. Parcellier A., Schmitt E., Brunet M., et al. Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions. Antioxid Redox Signal 7 (2005) 404-413
19. Takashi M., Katsuno S., Sakata T., et al. Different concentrations of two small stress proteins, alphaB-crystallin and HSP27 in human urological tumor tissues. Urol Res 26 (1998) 395-399
20. Mehlen P., Mehlen A., Guillet D., et al. Tumor necrosis factor-alpha induces changes in the phosphorylation, cellular localization, and oligomerization of human hsp27, a stress protein that confers cellular resistance to this cytokine. J Cell Biochem 58 (1995) 248-259
21. Kamradt M.C., Chen F., and Cryns V.L. The small heat shock protein alphaB-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem 276 (2001) 16059-16063
22. Kamradt M., Chen F., Sam S., et al. The small heat shock protein alphaB-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J Biol Chem 277 (2002) 38731-38736
23. Mao Y., Liu J., Xiang H., et al. Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ 11 (2004) 512-526
24. Kamradt M.C., Lu M., Werner M.E., et al. The small heat shock protein alphaB-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3. J Biol Chem 280 (2005) 11059-11066
25. Aoyama A., Steiger R.H., Frohli E., et al. Expression of alphaB-crystallin in human brain tumors. Int J Cancer 55 (1993) 760-764
26. Pinder S., Balsitis M., Ellis I., et al. The expression of alphaB-crystallin in epithelial tumors: a useful tumour marker?. J Pathol 174 (1994) 209-215
27. Chelouche-Lev D., Kluger H.M., Berger A.J., et al. alphaB-crystallin as a marker of lymph node involvement in breast carcinoma. Cancer 100 (2004) 2543-2548
28. Diaz L.K., Huo L., Gupta A., et al. Comparison of the effects of alcoholic formalin fixation to standard formalin fixation on estrogen receptor analysis by immunohistochemistry in beast cancer. Presented at the U.S. and Canadian Academy of Pathology (abstr 1462), Vancouver, British Columbia, Canada, March 6-12 (2004)
29. Diaz L.K., Gupta R., Kidwai N., et al. The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer. J Histochem Cytochem 52 (2004) 501-507
30. Donati V., Faviana P., Dell'omodarme M., et al. Applications of tissue microarray technology in immunohistochemisty: a study on c-kit expression in small cell lung cancer. Hum Pathol 35 (2004) 1347-1352
31. Packeisen J., Korsching E., Herbst H., et al. Demystefied...tissue microarray technology. Mod Pathol 4 (2003) 198-204
32. Torhorst J., Bucher C., Kononen J., et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 6 (2001) 2249-2256
33. Bryan B.B., Schnitt S.J., and Collins L.C. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol 5 (2006) 617-621
34. Werling R.W., Hwang H., Yaziji H., et al. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol 27 (2003) 82-90